"Predictive biomarkers" trang 1 - tải miễn phí từ tailieunhanh
Predictive biomarkers for the efficacy of nivolumab as≥ 3rd-line therapy in patients with advanced gastric cancer: A subset analysis of ATTRACTION-2 phase III trial

Predictive biomarkers for the efficacy of nivolumab as≥ 3rd-line therapy in patients with advanced gastric cancer: A subset analysis of ATTRACTION-2 phase III trial
10    25    1
Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients
8    93    1
Pre-operative biomarkers and imaging tests as predictors of post-operative delirium in non-cardiac surgical patients: A systematic review

Pre-operative biomarkers and imaging tests as predictors of post-operative delirium in non-cardiac surgical patients: A systematic review
16    35    1
Immune landscape of human prostate cancer: Immune evasion mechanisms and biomarkers for personalized immunotherapy

Immune landscape of human prostate cancer: Immune evasion mechanisms and biomarkers for personalized immunotherapy
10    64    1
Immunotherapy for non-small cell lung cancers: Biomarkers for predicting responses and strategies to overcome resistance

Immunotherapy for non-small cell lung cancers: Biomarkers for predicting responses and strategies to overcome resistance
10    50    1
Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary

Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary
95    64    0
Correlation between initial tumour volume and treatment duration on Dabrafenib: Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial

Correlation between initial tumour volume and treatment duration on Dabrafenib: Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial
8    51    0
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
9    67    0
Traffic lights for retinoids in oncology: Molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy

Traffic lights for retinoids in oncology: Molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
13    94    0
Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer

Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer
11    55    1
Response to post-axitinib treatment in patients with metastatic renal cell carcinoma

Response to post-axitinib treatment in patients with metastatic renal cell carcinoma
7    52    1
Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival

Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival
12    28    1
Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
11    37    1
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer
10    50    1
γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments

γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
13    76    1
MiR-200c and HuR in ovarian cancer

MiR-200c and HuR in ovarian cancer
14    61    1
Ovarian cycle stage critically affects 21- gene recurrence scores in Mmtv-Pymt mouse mammary tumours

Ovarian cycle stage critically affects 21- gene recurrence scores in Mmtv-Pymt mouse mammary tumours
12    60    1
Gut microbiome and its role in colorectal cancer

Gut microbiome and its role in colorectal cancer
13    38    3
Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients

Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients
16    49    1
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
15    16    1